Stotz M, Thümmler D, Schürch M, Renggli J-C, Urwyler A, Pargger H
Department of Anaesthesia, University of Basel/Kantonsspital, CH-4031 Basel, Switzerland.
Br J Anaesth. 2004 Dec;93(6):868-71. doi: 10.1093/bja/aeh269. Epub 2004 Sep 17.
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.